Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  IGI LABORIGI       

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 65,9 M
EBIT 2016 1,16 M
Net income 2016 -10,3 M
Debt 2016 54,5 M
Yield 2016 -
Sales 2017 93,4 M
EBIT 2017 14,2 M
Net income 2017 -1,65 M
Debt 2017 62,8 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 5,35x
EV / Sales 2017 3,86x
Capitalization 298 M
More Financials
Company
Teligent, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's products... 
Sector
Pharmaceuticals
Calendar
05/25Shareholder meeting
More about the company
Surperformance© ratings of IGI LABORIGI
Trading Rating : Investor Rating :
More Ratings
Latest news on IGI LABORIGI
05/17 TELIGENT : Gains More Than 2% FDA Approves ANDA For Triamcinolone Ointment
05/16 TELIGENT, INC. : Announces FDA Approval Of Triamcinolone Acetonide Ointment USP,..
05/13 STOCKS ACTIVE ON SELLING BOUNDARY : Horizon Pharma , Pretium Resources , Prima B..
05/10 TELIGENT, INC. : To Present At Bank of America Merrill Lynch Annual Health Care ..
05/03 TELIGENT, INC. : To Present At Deutsche Bank 41st Annual Health Care Conference ..
04/29 TELIGENT : reports 1Q loss
04/28 TELIGENT, INC. : Results of Operations and Financial Condition, Financial Statem..
04/28 TELIGENT, INC. : Announces First Quarter 2016 Results
More news
Sector news : Pharmaceuticals - NEC
11:25p NOVO NORDISK A/S : IDegLira receives positive 16-0 vote in favour of approval fr..
11:21p BAYER : Comments on Monsanto’s Statement Regarding Proposed Transaction
10:24p BAYER : Monsanto rejects $62B takeover bid from Bayer AG as 'inadequate'
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions